|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910808475603321 |
|
|
Autore |
Schweitzer Stuart O |
|
|
Titolo |
Pharmaceutical economics and policy [[electronic resource] /] / Stuart O. Schweitzer |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Oxford ; ; New York, : Oxford University Press, 2007 |
|
|
|
|
|
|
|
ISBN |
|
0-19-773783-8 |
1-283-05869-3 |
9786613058690 |
0-19-971974-8 |
|
|
|
|
|
|
|
|
Edizione |
[2nd ed.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (351 p.) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Pharmaceutical industry - United States |
Pharmaceutical policy - United States |
Pharmaceutical industry |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
pt. 1. The industry -- pt. 2. The consumer -- pt. 3. The market -- pt. 4. Intervention in the pharmaceutical market : public and private. |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
The pharmaceutical industry is praised as a world leader in high technology innovation and the creator of products that increase both longevity and quality of life for people throughout the world. At the same time, the industry is also criticized for its marketing and pricing practices and for its apparent anticompetitive responses to generic competition. Even its research and development priorities are criticized as being too closely driven by the goal of maximizing shareholder value, rather than the health of the public. Unfortunately, many of the critics of the industry fail to understand t |
|
|
|
|
|
|
|